• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears mammography workstation

Article

The regulatory path is clear for Hologic to begin marketing its SecurViewDX breast imaging workstation. The FDA earlier this month cleared the dedicated workstation for display and interpretation of screening and diagnostic digital mammograms, as well as

The regulatory path is clear for Hologic to begin marketing its SecurViewDX breast imaging workstation. The FDA earlier this month cleared the dedicated workstation for display and interpretation of screening and diagnostic digital mammograms, as well as other images such as MRI, CT, PET, and ultrasound. The workstation can also support digital CAD programs. It will complement Hologic's Lorad Selenia full-field digital mammography system, but its use will not be restricted to this system. The SecurViewDX is FDA cleared as an adjunct to any FDA-approved FFDM system.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.